Dataset Information

Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.

ABSTRACT: MicroRNAs are small regulatory RNAs that post transcriptionally control gene expression. Reduced expression of DICER, the enzyme involved in microRNA processing, is frequently observed in cancer and is associated with poor clinical outcome in various malignancies. Yet, the underlying mechanisms are not well understood. Here we identify tumour hypoxia as a regulator of DICER expression in large cohorts of breast cancer patients. We show that DICER expression is suppressed by hypoxia through an epigenetic mechanism that involves inhibition of oxygen-dependent H3K27me3 demethylases KDM6A/B and results in silencing of the DICER promoter. Subsequently, reduced miRNA processing leads to derepression of the miR-200 target ZEB1, stimulates the epithelial to mesenchymal transition and ultimately results in the acquisition of stem cell phenotypes in human mammary epithelial cells. Our study uncovers a previously unknown relationship between oxygen-sensitive epigenetic regulators, miRNA biogenesis and tumour stem cell phenotypes that may underlie poor outcome in breast cancer.

SUBMITTER: van den Beucken T

PROVIDER: S-EPMC4255228 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.

van den Beucken Twan T Koch Elizabeth E Chu Kenneth K Rupaimoole Rajesha R Prickaerts Peggy P Adriaens Michiel M Voncken Jan Willem JW Harris Adrian L AL Buffa Francesca M FM Haider Syed S Starmans Maud H W MHW Yao Cindy Q CQ Ivan Mircea M Ivan Cristina C Pecot Chad V CV Boutros Paul C PC Sood Anil K AK Koritzinsky Marianne M Wouters Bradly G BG

Nature communications 20141029

MicroRNAs are small regulatory RNAs that post transcriptionally control gene expression. Reduced expression of DICER, the enzyme involved in microRNA processing, is frequently observed in cancer and is associated with poor clinical outcome in various malignancies. Yet, the underlying mechanisms are not well understood. Here we identify tumour hypoxia as a regulator of DICER expression in large cohorts of breast cancer patients. We show that DICER expression is suppressed by hypoxia through an ep ...[more]

PMID: 25351418

Similar Datasets

Project description:Background: Hormonal therapy using progestins, acting through the progesterone receptor (PR), is a well-established method to treat uterine endometrial hyperplasia and carcinoma. Recent population studies indicate that progestin exposure significantly reduces the incidence of ovarian, pancreatic and lung cancers in addition to endometrial cancer in women. This unexpected differentiating function of progestin in organs outside of the reproductive system led us to hypothesize that progestins/PR are protective against cancer development and progression in many tumor types. Methods: The Cancer Genome Atlas, Oncomine and Prognostic Databases were searched to determine the relative expression of PR in tumors from multiple sites, and clinical outcomes linked to PR expression were determined. In addition, mRNA and protein expression were evaluated using real-time PCR and Western blotting. Chromatin immunoprecipitation (ChIP) assay was performed to understand the PR downregulation mechanisms in tumor cells and patient samples. Methylation-specific PCR was conducted to survey the PR methylation status. The Student’s t-test were performed to determine significance. Flow cytometry was used to quantify apoptotic cells. Results: Low PR expression levels were consistently linked to less favorable clinical outcomes in endometrial, pancreatic, ovarian and non-small cell lung cancers. Clinical specimens and cell lines from these cancers demonstrate low levels of PR, and we now report that the mechanism for loss of PR is mediated through epigenetic repression. However, PR silencing can be overcome with epigenetic modulators. Histone deacetylase inhibitor (LBH589) and hypomethylating agent (5-aza-decitabine) restored functional PR expression at both the mRNA and protein levels and promoted marked cell death through induction of apoptosis in the presence of progesterone. Conclusions: Our studies support the possibility that progestin therapy in combination with epigenetic modulators, a concept we term “molecularly enhanced progestin therapy”, is an approach worthy of study for malignancies originating from tissues outside of the reproductive tract.

Dataset Information

Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.

Publications

Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets